Categories
Analysis Forecast Business Report News

Worldwide Veterinary Imaging Market Ready To Set Outstanding Growth From 2019 To 2025

Market Scenario

The Global Veterinary Imaging Market is expected to register a CAGR of 7.14% to reach USD 2167.78 million by 2025. Veterinary imaging is the noninvasive method that helps to diagnose disease by making medical images of the veterinary body. We have various advanced imaging technology used for veterinary patients. Veterinary imaging instruments are used to diagnosis of chronic disease and getting medical images of animals. Notably, the increasing prevalence of zoonotic diseases, significant rise in pet insurance purchases, and increased number of veterinary practitioners are promoting the growth of the veterinary imaging market globally.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2919

The market growth is mainly driven by increasing incidence of zoonotic diseases, increasing expenditure on pet insurance, and technological advancements in veterinary imaging. However, high procedure cost and lack of skilled veterinarians may slow the growth of the market.

Market Dynamics

Increasing expenditure on the pet is driving the growth of the Veterinary Imaging market demand. Pet insurance covers various minor to major medical expenses such as accidents, chronic conditions, wellness, and routine care coverage, medication coverage, diagnostic testing and imaging, others. Though pet insurance does not provide 100% coverage, it reimburses around 80% of the total pet medical expenses. According to the North American Pet Health Insurance Association (NAPHIA), North America’s pet health insurance growth was exceeded by 17.2% from 2014 to 2015. It is also reported that the total number of insured pets reached 1.6 million at the end of 2015.

Pet owners spend a lot on routine vet expenses and surgical vet visits. As per the data suggested by The American Pet Products Association (APPA), around 65% of the US population owns a pet, and the US pet industry expenditure in 2015 was USD 60.3 million, which is exceeded to USD 62.8 million. Thus, with the growing spending on animal healthcare, the demand for veterinary diagnosis and the equipment required for the same will also increase, which boosts the growth and veterinary imaging market size.

Segmentation

The global veterinary imaging market is segmented into product type, animal type, therapeutic area, and end user. On the basis of product type, the market is segmented into instruments, veterinary imaging reagents, and veterinary software. On the basis of animal type, it is segmented into small companion animals and large animals. On the basis of the therapeutic area, the veterinary imaging market segmented into orthopedics and traumatology, cardiology, neurology, and oncology. On the basis of end user, the Veterinary Imaging market segmented into hospitals & clinics, and academic institutes.

Regional Analysis

The global veterinary imaging market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas accounted for the largest market share in 2018, and the regional market is projected to register a CAGR of 7.62% during the forecast period. The larger share is majorly attributed to the growth in adoption of pet animals, increasing veterinary healthcare expenditure, increasing demand for pet insurance, and increasing pet ownership. According to the report published by the American Pet Products Association, from 2017 to 2018, 68% of the US households or 85 million families have a pet.

Europe is the second-largest market for veterinary imaging owing to the presence of large market players, innovative advanced technology, increasing companion animal ownership, and the presence of veterinaries.

The Asia Pacific region accounted the third-largest market owing to the presence of large animal population, increasing disposal income, increasing nuclear families preferring to have pets and increased investments by the American and European market giants in Asian countries such as China and India. India held a share of 15.9% in the Asia-Pacific veterinary imaging market in 2018.

The market in the Middle East and Africa is constrained due to poor development of the animal industry and the low productivity of the maximum breeds in the region.

Key Players

The prominent players in the global veterinary imaging market are Esaote SpA (Italy), GE Healthcare (US), Medical Imaging/IMCO, Inc. (US), BCF (Scotland), Fujifilm Holding Corporation (Japan), Heska Corporation (US), Diagnostic Imaging System, Inc. (US), Canon Inc. (Tokyo), Carestream Health (US), and Merry X-Ray (US).

The players operating in the global veterinary imaging market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

  • In March 2019, Esaote SpA launched the new ultrasound platform MyLabX8 for increasing efficiency of ultrasound machines and to maintain the workflow.
  • In October 2018, GE Healthcare announced a strategic collaboration with SonoSim to encourage education and training about ultrasound devices. This collaboration is likely to help the company to increase its customer base.
  • In June 2018, Fujifilm Holding Corporation acquired Irvine Scientific Sales Company, Inc. for USD 800 million. With this acquisition, Fujifilm is likely to enter into the cell culture media business.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919  

Detailed Table of Contents:

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition

3.2 Scope Of The Study

3.3 List Of Assumptions

3.4 Market Structure

4 Research Methodology

4.1 Research Process

4.2 Primary Research

4.3 Secondary Research

4.4 Market Size Estimation

4.5 Forecast Model

5 Market Dynamics

5.1 Introduction

5.2 Drivers

5.2.1 Increasing Incidence Of Zoonotic Diseases

5.2.2 Increasing Expenditure On Pet Insurance

5.2.3 Technological Advancements In Veterinary Imaging

5.3 Restraints

5.3.1 High Procedure Cost

5.3.2 Lack Of Skilled Veterinarians

…TOC Continued!

Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/2919         

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]

 

Categories
News

Immunoassays in R&D Market Cagr Growth Expected To Be Linear To The Skyrocketing Rise ! Predicted By 2023

Market Scenario

The Global Immunoassay In R&D Market Size is expected to register a CAGR of 8.18% and is anticipated to reach USD 475.3 million by 2023. Immunoassays are analytical methods in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Immunoassays incorporate a variety of different labels for the detection of antibodies and antigens. These labels are generally chemically linked or conjugated to the desired antibody or antigen.

The increasing incidence of chronic and infectious diseases, growing research and development investment (R&D) activities, and technological advancements are the major factors boosting the growth of the market. Despite the drivers, the high cost of immunoassay procedures and the high price of immunoassay systems constrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7892

Market Players

Market Research Future (MRFR) recognizes the following companies as the key players in the global immunoassay in R&D market that includes Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), bioMérieux Inc. (France), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Sysmex Corporation (Japan), and Abcam plc (United Kingdom).

Segment Analysis

The global immunoassay in R&D market has been segmented into type, application, and end user. By type, the market has been segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Enzyme-Linked Immunospot Assay (ELISpot), Radioimmunoassay (RIA), Chemiluminescence (CLIA), Fluoroimmunoassay, and Others. On the basis of application, the market has been segmented into infectious diseases, cancer research, endocrinology, autoimmune diseases, and others. By end-user, the market has been segmented pharmaceutical and biotechnology companies, academic institutions and laboratories, and others

Regional Analysis

Geographically, the Americas is expected to dominate the global immunoassay in R&D market. The market growth is attributed to the increasing number of research projects in laboratories, growing adoption of advanced technology in research, and the growing prevalence of several diseases. The European market for immunoassay in R&D is expected to be the second-largest market due to the growing adoption in diagnostic measures is expected to boost the growth of the market in this region.

Moreover, the companies operating in the market are particularly focusing on mergers and acquisition which is expected to support the market growth. Asia-Pacific is estimated to be the fastest growing market due to the developing healthcare infrastructure and increasing disposable income. In addition to this, improving healthcare infrastructure has increased the number of research activities in the region. Moreover, in the Asia-Pacific region, South Korea accounted for a market share of 10.1% in 2017. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare facilities.

Key Findings of the Study:

  • Global immunoassay in R&D market is projected to reach USD 3 million by 2023 with 8.18% CAGR during the review period of 2018 to 2023
  • The pharmaceutical and biotechnology companies segment accounted for a market value of USD 174.3 million in 2017

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/immunoassay-in-r-d-market-7892

Detailed Table Of Contents of Global Immunoassay in R&D Market

TABLE OF CONTENTS

1 Report Prologue

2 Market Introduction

2.1     Definition

2.2     Scope Of The Study

2.3     List Of Assumptions

2.4     Market Structure

3 Research Methodology

3.1     Research Process

3.2     Primary Research

3.3     Secondary Research

3.4     Market Size Estimation

3.5     Forecast Model

4 Market Dynamics

4.1     Overview

4.2     Drivers

4.2.1   Increasing Incidence Rate Of Chronic And Infectious Diseases

4.2.2   Increased R&D Investments By Public And Private Organizations

4.2.3   Technological Advancements In Immunoassay Testing

4.3     Restraints

4.3.1   High Cost Of Immunoassay Procedures

4.3.2   High Price Of Immunoassay Systems

4.4     Opportunity

4.4.1   Integration Of The Microfluidics Technology In Immunoassays

4.5     Challenge

4.5.1   Technical Difficulties During Testing

5 Market Factor Analysis

5.1     Value Chain Analysis

5.1.1   R&D And Product Development

5.1.2   Manufacturing

5.1.3   Distribution & Sales

5.1.4   Post-Sales Monitoring

…TOC Continued!

Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/7892

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]

Categories
COVID-19 Market Impact

Somatostatin Analogs Market 2020 Trends, Size Analysis, Share, Leading Companies

Market Highlights
 
The growth of the global somatostatin analogs market is driven by various factors such as increasing research & development activity in the somatostatin analogs market and increasing numbers of players involved in the development of generic versions of somatostatin analogs. Some of the key companies operating in this market are Nodysis Pharma, United Biotech, Wockhardt, Neiss, Sun Pharma, and Ferring Holding SA, among others. In addition, the rising incidence rate of the NETs; and increasing efforts by government bodies and public and private organizations to increase awareness about Acromegaly are some of the other factors for the growth of the somatostatin analogs market.
 
However, lack of awareness leading to a high number of undiagnosed people, and the availability of the alternative treatment options for the treatment of NETs and Acromegaly are thwarting the growth of the somatostatin analogs market.
According to MRFR analysis, Somatostatin Analogs Market is expected to register a CAGR of 6.8% during the forecast period of 2019 to 2025 and is anticipated to reach USD 8,640 Million by 2025.
The Global Somatostatin Analogs Market was dominated by a few players in the past. However, the increasing demand for treatment options is creating opportunities for new entrants to step into the market. Thus, there is a change in the competitive scenario in the somatostatin analogs market. A large number of companies in the market, such as Camurus AB and Chiasma Inc., among others have the product pipeline of somatostatin analogs. The increasing number of companies bring more investments in the market which positively impacts the growth of the market.
 Regional Analysis
 
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increased awareness about NET’s and high per capita disposable incomes. The somatostatin analogs market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The high occurrence of NET’s in US is one of the reasons for the growth of the market in the country. The European somatostatin analogs market is the fastest-growing market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The presence of a number of product manufacturers such as Novartis AG (Switzerland), Ipsen Pharma (France), Fresenius Kabi (Germany) is one of the factors pushing the growth of the regional market. The somatostatin analogs market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising per capita healthcare expenditure and growing awareness towards the treatment of acromegaly and NETs, the market in Asia-Pacific is expected to grow at a significant rate during the forecast. The somatostatin analogs market in the Middle East & Africa has been divided into the Middle East and Africa.
 
Segmentation
 
The Global Somatostatin Analogs Market has been Segmented Based on Type and Application. The market, based on type, has been divided into Octreotide, Lanreotide, and Pasireotide. The Octreotide segment is likely to hold the largest during the review period as it is the most commonly used type of vaccine and is commercially available across the globe. Pasireotide is predicted to be the fastest-growing segment due to the growing awareness about the treatment options for Cushing’s Syndrome which is commonly treated by Pasireotide.
The global somatostatin analogs market has been segmented, on the basis of application, into neuroendocrine tumors (NETs), acromegaly, Cushing’s syndrome, and others. The neuroendocrine tumor segment is expected to hold the maximum share of the market throughout the forecast period. The acromegaly segment is expected to be the fastest-growing during the assessment period.

Key Players

Some of the Key Players in the Global Somatostatin Analogs Market are Novartis AG (Switzerland), Ipsen Pharma (France), Fresenius Kabi (Germany), Peptron (South Korea), Pfizer Inc. (US), and Teva Pharmaceuticals Inc. (Israel).
 
Besides these key players, there are several potential market entrants which are working on the pipeline products in the somatostatin analogs market. Some of these players are Camurus AB (Sweden), Chiasma, Inc. (US), Crinetics Pharmaceuticals (US), Dauntless Pharmaceuticals (US), Midatech Pharma plc (UK), and Sun Pharmaceutical Industries Ltd (India), among others.

Related Trending Reports

Plastics Market

Laboratory Equipment Market

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services

Contact:
https://www.marketresearchfuture.com/

Categories
COVID-19 Market Impact

HIP IMPLANTS MARKET 2020 Trends, Size Analysis, Share, Leading Companies

Market Research Future published a research report on Hip Implants Market Research Report – Global Forecast till 2025. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.

Key Players

Some of the key players in the global hip implants market are Corin (UK), DJO Global, Inc. (US), OMNILife science, Inc. (US), MicroPort Scientific Corporation (China), Stryker Corporation (UK), Zimmer Biomet Holdings, Inc. (US), Smith & Nephew PLC (UK), Exactech, Inc. (US), B. Braun Melsungen AG (Germany), and Aesculap Implant Systems, LLC (US).

Segmentation

The global Hip Implants Market has been segmented based on the product, material, and end user.

The market, based on product, has been divided into total hip replacement implants and partial hip replacement implants. Total hip replacement segment is further segmented into fixed-bearing hip implants and mobile-bearing total hip implants. The partial hip implants segment has been further bifurcated into hip resurfacing implants and revision hip replacement implants.

The total hip replacement implants segment is likely to be the largest during the review period due to the increasing geriatric population and prevalence of hip-related disorders. The partial hip replacement implants devices segment is predicted to be the fastest-growing due to less deterioration and friction than all-metal hip implants.

Get full report @

www.marketresearchfuture.com/reports/hip-implants-market-8448

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The hip implants market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada. The European hip implants market has been categorized as Western Europe and Eastern Europe. The Western European market has been further classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hip implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the growing geriatric population and increasing demand for hip replacement surgeries, the market in Asia-Pacific is expected to be the fastest-growing.

Latest Trending Reports

Patient Lift Slings Market

Liver Cirrhosis Treatment Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Categories
Analysis Forecast Business Report Coronavirus COVID-19 Market Impact News Space

mHealth Market Key Findings, Top Leaders and Forecast to 2022

Market Overview:

The report also studies the impact of various technologies on it. It is an efficient technology backed by top-class IT infrastructure. Digitalization made its percolation easier. Rising sale of smartphones and tablets are going to spur the demand for the same. Increasing care for personal health, better disposal income, easy inclusion of wireless technologies, portability, cost-effective features, change in lifestyle, and others can ensure strong growth for the mHealth market.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1816

The study of the mHealth Market Share, as conducted by Market Research Future (MRFR) reveals that it has a possibility of surpassing a valuation of USD 21.71 billion by 2022. This process would see a rise by a significant CAGR of 36.5% during the forecast period (2016-2022).

 

Competitive Analysis:

The global mHealth market to gain significant backing from companies like Alivecor, INC, Apple, INC, Agamatrix, INC, AT&T, INC, Athenahealth INC, GE Healthcare, Google INC, Biotelemetry INC. (CARDIONET), Johnson & Johnson, Jawbone INC, Philips Healthcare, Laboratory Corporation of America Holdings

 

Segmentation:

The global mHealth market report includes several segments that have been studied properly to understand dynamics dominating the market. This study includes segments on the basis of therapeutics and applications.

By therapeutics, the report on the global mHealth market can be segmented into fitness & lifestyle therapeutics, respiratory, mental and neurological disorders, diabetes, and others. The rise of diabetes among people is going to trigger further growth for the mHealth market.

By application, the global market report on mHealth can be segmented into diagnosis & treatment, monitoring applications, wellness & prevention, healthcare management, education and awareness, remote data collection, and others. The remote data collection segment is aiding the research sector in a significant way. The monitoring segment has a hold over 61.8% of the global market.

Regional Analysis:

The global market for mHealth has been analyzed in the report. It includes several aspects of the demographic challenges to understand how far the players can benefit from various growth factors.

The Americas is slated to lead the mHealth market by creating ample scope for growth through funding for research and development, and other marketing strategies. The nod it is getting from the government has ensured significant progress for the market in the coming days. IT infrastructure is getting better and a lot of caregivers would help the market to increase by creating high intake. The regional market covers almost 34% of the entire market share. In Europe, the market is getting similar acknowledgments and it is on an upward track. High investment for research and development and better backup from technological inclusion are expected to ensure the growth of the market. This regional market can grow with 35.65% CAGR during the forecast period.

The Asia Pacific region is on a track where achieving the highest CAGR is quite possible. This is due to the growing investment from several economies to ensure better healthcare infrastructure, to reach distant corners where easy healthcare facilities are not available, and also, they can avail it at a cheaper rate. India, China, Thailand, Japan, and Australia are helming the market by launching different innovations.

Industry News:

In January 2020, the Rady Children’s Institute for Genomic Medicine (RCIGM) announced that they are planning on investing in drones to collect genomic samples to speed up the procedure of treatment. They believe that this would significantly boost the treatment of critically ill children.

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Categories
Analysis Forecast Business Report Coronavirus COVID-19 Market Impact News

Digital Healthcare Market Outlook, Competitive Landscape and Forecast to 2025

 

Market Overview:

 

The high adoption rate of EHR and EMR is expected to play in favor of the digital healthcare market. The telemedicine sector is also getting boosted from the pressures created by COVID-19. Various updates, growing demand for easier workflow, and a curb in the healthcare cost are impacting the growth of the digital healthcare market. Various digital healthcare market trends like simplified apps are also boosting progress.

 

The global Digital Healthcare Market Trends has been predicted to reach a valuation of USD 3,28,887.8 million by 2025, with a CAGR of 26.30% during the forecast period of 2019 to 2025. Market Research Future (MRFR), in its analysis, reports various factors that can have a substantial impact on the market.

 

Get a Free Sample @

https://www.marketresearchfuture.com/sample_request/7636

 

The digital healthcare industry overview also reveals restraints like the installation cost, the cost of apps, and the lack of trained hands as major drawbacks for the market.

 

Competitive Landscape:

 

BioTelemetry, Inc. (US), Allscripts Healthcare, LLC (US), Cisco Systems, Inc (US), Cerner Corporation (US), McKesson Corporation (US), Koninklijke Philips NV (The Netherlands), AT&T Inc.(US), General Electric Company (US), EClinicalWorks (US), iHealth Lab Inc. (US), Athenahealth Inc. (US), and Qualcomm Technologies, Inc.(US).

 

Segmentation:

 

  • The global digital healthcare market, as assessed by MRFR for a comprehensive understanding, includes the application, components, delivery mode, technology, and end user. These are segments with substantial market figures and factors to support the global strategic developments of the digital healthcare market.

 

  • By technology, the study on the digital healthcare market can be segmented on the basis of telehealthcare, mhealth, digital health systems, and healthcare analytics. By application, the digital healthcare market includes diabetes, neurology, cardiology, oncology, sleep apnea, and others.

 

  • By delivery mode, the global report for the digital healthcare market can be segmented on the basis of on-premise and cloud-based.

 

  • By components, the digital healthcare market includes software, services, and hardware.

 

  • By end user, the digital healthcare market has been segmented into healthcare payers, pharmaceutical companies, healthcare providers, and others.

 

Regional Analysis:

 

North America has a bigger market due to the advancement in its technology, support from infrastructure, funding solutions, and others. The US and Canada would lead the regional market. In Europe, the traction will be provided by countries like France, Germany, the UK, and others. The Asia Pacific region would benefit from contributions made by India, China, Japan, South Korea, and others.

 

Industry News:

 

The recent COVID-19 pandemic has led to a substantial rise in the digital healthcare market. This is primarily due to the growing influence of telemedicine. Social distancing is the new norm and people are supposed to avoid public gathering. This is why doctors are taking the telemedicine route where they can treat patients from a distance without creating a scope for any kind of virus spread.

 

 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

 

Categories
Analysis Forecast Business Report Coronavirus COVID-19 Market Impact News

Life Science Analytics Market Overview, Business Dynamics and Forecast to 2025

 

Market Analysis

 

The global life sciences market size was valued USD 19,165.22 million in 2018 and is predicted to grow at an 11.91% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report. Life science analytics, simply put, is a tool that assists in drug discovery optimization process and clinical trials standardization. Prescriptive analytics, descriptive analytics, and predictive analytics are the most widely used life science analytics. The Cerner Millennium software and Allscripts’ Veradigm are the latest life sciences industry trends.

 

Numerous factors are adding to the Life Sciences Market Overview . Such factors, as revealed by the latest MRFR report, include increasing use of big data in the life science industry, the need for improved patient outcomes, increasing use of analytics tools for marketing applications and sales, and rising adoption of analytics solutions in clinical trials. Additional factors propelling the life sciences healthcare analytics market growth include rising incidence of chronic diseases, need for improved standardization, and rising pressure to reduce healthcare expenditure.

 

On the contrary, dearth of professionals and high implementation costs are factors that may limit the life science market growth over the forecast period.

 

Scope of the Report

 

The report categorizes the life science analytics market based on end user, deployment model, component, application, and type of analytics, regions, and key players. Life science analytics helps to capitalize on big data to improve the global collaboration resting on the precise clinical research information. It helps in standardizing the clinical trials data along with validating its adherence. In fact, advanced analytics helps early detection of prospective risks as well as proactively address the same.

Key Players

 

IQVIA (US), Oracle (US), IBM (US), SAS Institute Inc. (US), SCIOInspire, Corp. (US), Optum, Inc. (US), Saama Technologies, Inc. (US), McKesson Corporation (US), Inovalon (US), Health Catalyst (US), CitiusTech Inc. (US), Cerner Corporation (US), and Allscripts Healthcare, LLC (US).

 

 

Life Science Market Segmentation

 

  • The MRFR Report provides an inclusive segmental analysis of the life science analytics market based on end user, deployment model, component, application, and type of analytics.

 

  • By type of analytics, the life science analytics market is segmented into prescriptive analytics, descriptive analytics, and predictive analytics. Of these, descriptive analytics will lead the market over the forecast period for its increasing preference by life science companies as they work wonders to understand past trends.

 

  • By application, the life science analytics market is segmented into supply chain optimization, sales and marketing, regulatory compliance, pharmacovigilance, and research & development. Research and development is again segmented into preclinical trials and clinical trials. Of these, research and development will dominate the market over the forecast period for the increasing use in the research and development activities to develop innovative life science products.

 

  • Based on component, the life science analytics market is segmented into hardware, services, and software. Of these, the software segment will have a major share in the market over the forecast period for the increasing use of analytics software in the life science industry.

 

  • By deployment model, the life science analytics market is segmented into cloud-based, on-premise, and deployment model. Of these, the on-premise model will command the largest share in the market over the forecast period.

 

  • By end user, the life science analytics market is segmented into biotechnology and medical device companies, pharmaceutical, hospitals and clinics, and others. Of these, hospitals & clinics will spearhead the market over the forecast period as it augments healthcare productivity and minimizes clinical errors.

 

Regional Analysis

 

By region, the global life science analytics market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period for increasing adoption of healthcare IT solutions and increasing healthcare spending.

 

The life science analytics market in Europe is predicted to have the second-largest share over the forecast period for better availability of healthcare services and solutions, technological advancements, and increasing incidence of chronic diseases.

 

The life sciences analytics market in the APAC region is predicted to grow at a fast pace over the forecast period. The presence of several healthcare IT companies and fast-developing life sciences industry are adding market growth.

 

The life sciences analytics market in the MEA is predicted to have significant growth over the forecast period for rapid technological advancements and increasing support from the government to develop the healthcare IT industry.

 

 

Categories
Analysis Forecast Business Report COVID-19 Market Impact News

Prefilled Syringes Market Size, Strategies, SWOT Analysis and Forecast to 2024

Market Overview:

Prefilled syringes are defined as disposable syringes (meant for one-time use) that are alreadyfilled with the pharmaceutical substances that ares to be injected into the patient’s body. A new report on the global prefilled syringes market, published by Market Research Future (MRFR),points out that this market could see a rise at 10.20% CAGR between 2016 and 2024. In terms ofmoney value, the market can be worth USD 8397.23 Mn by the end of the forecast period.

 

A new report on the global Prefilled Syringes Market Share published by Market Research Future (MRFR), points out that this market could see a rise at 10.20% CAGR between 2016 and 2024. In terms of money value, the market can be worth USD 8397.23 Mn by the end of the forecast period.

 

Key Players:

  • Abbott
  • Baxter International
  • Becton Dickinson & Company
  • Gerresheimer AG
  • Medtronic
  • Nipro Corporation
  • OMPI
  • Schott AG
  • Terumo Corporation
  • Vetter Pharma International GmbH
  • Weigao Group
  • West Pharmaceutical

 

Market Segmentation:

  • The global prefilled syringes market segmentation encompasses design, end-user, material, and type. MRFR’s take on the market surveys various facets of the market in-depth.
  • The design-based segmentation of this market covers single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. During the forecast period, the dual-chamber prefilled syringes segment is expected to grow at 10.31% CAGR. Single-chamber prefilled syringes segment is expected to hold the larger market share of 56% in the global market.
  • Regarding end-users, the market has been segmented into the ambulatory surgical center and hospitals/clinics. Due to the growing number of public hospitals as well as private hospitals, the hospitals segment has been anticipated to grow faster during the forecast period.
  • Based on material, the market has been segmented into glass prefilled syringes and plastic syringes. The glass prefilled syringes segment has been sub-segmented into baked on silicone syringes and oil siliconized syringes. Plastic syringes segment has higher growth due to its usage in many applications of pharmaceutical packaging during the forecast period.
  • By type, the market has been segmented into conventional prefilled syringes and safety prefilled syringes. Conventional prefilled syringes held the larger market share of about 68% in 2017.

 

Regional Segmentation:

The regional analysis of the prefilled syringes market globally consists of regions is divided into Europe, Americas, Asia Pacific, Middle East and Africa.

The European region is responsible for the leading market share of about 41.4 percent in the year 2017 and is expected to lead the prefilled syringes market globally. The higher share is majorly attributed to the rising geriatric population, demand for quality healthcare and growing trend of home-based treatment separate with high healthcare expenditure.

The Americas region is responsible for the second biggest market portion, whereas the Asia Pacific region is anticipated to develop at a rapid expansion rate of about 10.78 percent during the forecast period. With loads of prospects and unceasingly developing economies, the region is expected to be among the rapidly growing area. Moreover, factors such as Japan’s quick adoption of plastic devices along with the modern healthcare developments, and increasing number of private and public hospitals, are promoting the growth of the market.

The Middle East and Africa region with a lesser degree of economic developments and very low-income per capita is responsible for the minimum market share in 2017 but is likely to develop in the future.

 

Latest Industry News

  • Made by Regeneron, chemistry, manufacturing, and controls prior-approval supplement for the Eylea injection prefilled syringe that has been approved by the USFDA. 13 AUG 2019

 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Categories
News

Albumin (as Excipient) Market Size, Global Opportunity, Demand by Manufacturing Base Distribution Analysis 2019 to 2023

Albumin (as Excipient) Market Research Report: By Type (Human, Bovine, and Recombinant Serum Albumin), Application (Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Diagnostics, and Others), End User – Global Forecast Till 2023

Market Introduction

The global albumin (as excipient) market is expected to grow at an approximate CAGR of 6.1% during forecast period, 2018–2023.

Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based VELTIS technology is used by GlaxoSmithKline plc in the manufacturing of type II diabetes drug (Tanzeum and Eperzan) in Europe.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/7442 

Various other factors such as increasing prevalence of chronic conditions, technological advancements, emerging markets in APAC and RoW, rising awareness about albumin as excipient, and increase in usage of albumin for non-therapeutic applications are also expected to propel the growth of the market.

Key Players

Some of the key players in the global albumin (as excipient) market are Albumedix A/S, Albumin Therapeutics, LLC, Baxalta Incorporated, Baxter International Inc., Biotest AG, CSL Behring LLC, Celgene, China Biologic Products, Inc., Grifols International, S.A, HiMedia Laboratories Pvt. Ltd., InVitria, Medxbio Pte Ltd., Mitsubishi Tanabe Pharma Corporation, Octapharma AG, RayBiotech, Inc., SeraCare Life Sciences, Sigma-Aldrich Co. (Merck KGaA), and others.

Market Segmentation

The global albumin (as excipient) market is segmented based on type, application, end user, and region.

The global market for albumin (as excipient), by type is segmented into human serum albumin, bovine serum albumin, and recombinant albumin. The human serum albumin segment is anticipated to hold the largest market share owing to the increasing cases of chronic conditions such as, cardiac disorders, infectious diseases, and others.

Based on application, the market is segmented into drug formulation, drug delivery, vaccines, medical device coating, culture media & stabilizers, diagnostics, in vitro fertilization, and others.

Based on end user, the market is segmented into pharmaceutical & biotechnology industry, academic and research institutes, and others.

Intended Audience

  • Government and Private Laboratories
  • Research and Development (R&D) companies
  • Biotechnology Laboratories
  • Market Research and Consulting Service Providers

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/albumin-market-7442  

Regional Analysis

The Americas dominated the global market for albumin (as excipient) owing to the rising R&D investments and increasing prevalence of diabetes within the region. According to the 2015 data suggested by the Centres for Disease Control and Prevention (CDC), around 30.3 million Americans were suffering from diabetes.

In 2017, it was estimated that Europe stood second in the global albumin (as excipient) market. This can be attributed to the increasing technological advancements, and rising participation of market players. For instance, in 2016, a Denmark based company, Novozymes launched its recombinant albumin business as a new independent called Albumedix.

Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure drives the regional markets of the Asia Pacific region. As per the data suggested by the Australian Institute of Health and Welfare, from 2015 to 2016, the total health expenditure was USD 181 billion.

On the other hand, the Middle East and Africa held least share in the global albumin (as excipient) market due to inadequate economic development, especially within the African region.

Inquire for exclusive Discount at https://www.marketresearchfuture.com/check-discount/7442

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: [email protected]

Categories
News

Oligonucleotide Pool Market Technological Advancements by Major Applications, Trend Analysis and Research Report 2020, Forecast to 2024

Oligonucleotide Pool Market Synopsis

Oligonucleotide pool allows the precise design and synthesis of thousands of user-defined sequences in parallel which can be utilized in high-throughput screening experiments for identification of novel gene mutations, optimization of protein structure, and function, or for drug discovery. Oligonucleotide pool is used in various research applications for designing and synthesizing of genes.

Considering the exponential traction, the market perceives currently Market Research Future (MRFR) in its recently published study report asserts that the global oligonucleotide pool market will reach USD 2.32 Billion by 2022, registering approximately 8.5% CAGR throughout the forecast period (2018 – 2022).

Get Free Sample Copy with Complete TOC at https://www.marketresearchfuture.com/sample_request/2556

The synthesizing of the oligonucleotide pool has significantly advanced scientific research, diagnostic development, and drug discovery.  This, as a result, is driving the global oligonucleotide pool market. Moreover, advantages of oligonucleotide pool such as low-cost, fast analysis methods with precisely high accuracy are allowing its market to garner phenomenal traction on the global platform. .

Some of the players leading the global oligonucleotide pool market include

  • Creative Biogene
  • Agilent Technologies
  • CustomArray Inc.
  • MYcroarray
  • Integrated DNA Technologies Inc.
  • Sigma Aldrich
  • Twist Bioscience
  • and TriLink BioTechnologies among others.

Additional factors boosting the market growth include the growing complimentary industries, augmented adoption of precision medicine, and the increasing applications of oligonucleotide pool in biotechnology and molecular biology. Besides, huge investments made by the pharmaceutical giants in oligonucleotide therapeutics for drug development are fostering the growth of the market.

On the flipside, the nascent stage of the oligonucleotide pool is a considerable headwind that is posing some challenges to the market growth such as the lack of funds for R&D and the high cost of development. Nevertheless, substantial funding programs from private and public organizations that are increasing rapidly are expected to support the market growth providing sufficient funds for R&D.

Oligonucleotide Pool Market   – Segmentation

MRFR has segmented its analysis into four key dynamics for enhanced understanding.

By Type                            : DNA Pool and RNA Pool among others.

By Application              : Research, Diagnostics, and Therapeutics among others.

By End-user                   : Commercial Research and Pure Academic Research among others.

By Regions                     :  Europe, North America, APAC, and the Rest-of-the-World (RoW).

Browse Complete Premium Research Report at https://www.marketresearchfuture.com/reports/oligonucleotide-pool-market-2556

Global Oligonucleotide Pool Market   – Regional Analysis

The North American region dominates the global oligonucleotide pool market owing to the presence of leading global players and encouraging governmental support for the research & development activities in healthcare.  Moreover, factors such as the increased uptake of advanced technologies and high healthcare expenditures encourage market growth. The market is further expected to grow at 8.6% CAGR from 2018 -2022.

The oligonucleotide pool market in the US backed by the increasing demand for tests of gene functions, majorly contributes to the growth of the regional market. Heading with the rising demand, the region is expected to create a larger revenue pocket, globally, by 2022.

The European oligonucleotide pool market accounts for the second-largest market. Factors facilitating the growth of the regional market include the recent technological advancements and their huge uptake in the medical sector.  Also, the rising healthcare expenditure is expected to foster market growth in the region. Besides, support and funding programmes from public & private organizations for research & development positively impacts the growth of the regional market. As a result, the European oligonucleotide pool market is expected to grow at 8.7% CAGR from 2018-2022.

The oligonucleotide pool market in the Asia Pacific region is emerging as a profitable market, heading with enormous contributions from some of the Asian countries such as South Korea, China, Japan, and India. With the rising demand for gene tests and increasing adoption of these techniques in various procedures, APAC market is expected to register a CAGR of 9.2% during the forecast period.

Inquire for an Amazing Discount at https://www.marketresearchfuture.com/check-discount/2556

Global Oligonucleotide Pool Market   – Competitive Analysis

The fiercely competitive oligonucleotide pool market appears to be fragmented with many well-established as well as small players and new entrants forming the competitive edge. New technology launch, brand reinforcement, and innovation remain the prevailing trends of the key players. The growth statistics of the market indicate towards the probable heights the market can reach further.

About Market Research Future: Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: [email protected]